Fundraising FoxPrincipia Biopharma
South San Francisco, US · Delaware corporation · 10 known investors
Find your way into Principia Biopharma
25 people in our graph can introduce you to the Principia Biopharma team.
Sign up to see every warm intro you have to Principia Biopharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Principia Biopharma team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
Investors · 10
How we know: Access Biotechnology's portfolio page · Not right? Tell us
How we know: Mission Biocapital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Sofinnova Ventures's portfolio page · funding news · the VCSheet dataset · Not right? Tell us
How we know: SR One Capital Management's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
How we know: a partner's Signal profile · funding news · prnewswire.com · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements$65.3M disclosed across 2 of 3 rounds · 2012–2018
- Undisclosed amountSeries AOct 2012
Mission Bay Capital (lead), Morgenthaler Ventures (lead), New Leaf Venture Partners (lead), OrbiMed Advisors (lead), SROne (lead)
Source ↗
▶$50MraisedSep 2018 · 24 investors · BiotechnologyRule 506(b)
- Simeon GeorgeDirector
- Alan ColowickDirector
- Srinivas AkkarajuDirector
- Nassim UsmanDirector
- Peter ThompsonDirector
- Daniel BeckerDirector
- Martin BablerExecutive Officer, Director
- Lewis J. ShusterDirector
- Offering amount
- $50M
- Amount sold
- $50M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.3MraisedAug 2015 · 13 investors · BiotechnologyRule 506(b)
- MARTIN BABLERExecutive Officer, Director
- PETER THOMPSONDirector
- SRINIVAS AKKARAJUDirector
- LEWIS J. SHUSTERDirector
- MICHAEL DYBBSDirector
- SIMEON GEORGEDirector
- NASSIM USMANDirector
- Offering amount
- $15.3M
- Amount sold
- $15.3M
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
5 people who came through Principia Biopharma went on to found or lead other companies.
In the news
Frequently asked questions
- Who are Principia Biopharma's investors?
- Principia Biopharma's investors include Access Biotechnology, Mission Biocapital, Sofinnova Ventures, SR One Capital Management, Mission Bay Capital, New Leaf Venture Partners, OrbiMed, Samsara BioCapital.
- How much funding has Principia Biopharma raised?
- Principia Biopharma has disclosed $65.3M raised across 2 of its 3 known rounds.
- Where is Principia Biopharma headquartered?
- Principia Biopharma is headquartered in South San Francisco, US.